Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1999 Sep;128(1):103-7.
doi: 10.1038/sj.bjp.0702746.

[Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray

Affiliations
Comparative Study

[Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray

L C Chiou. Br J Pharmacol. 1999 Sep.

Abstract

1. [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 (Phepsi), a tridecapeptide analogue of orphanin FQ/nociceptin (OFQ/N), was introduced as a competitive antagonist of opioid receptor-like orphan receptor (ORL1) in guinea-pig ileum and mouse vas deferens preparations in vitro but was recently found to act as an agonist in vivo. 2. In the periaqueductal gray, a site enriched with both OFQ/N and ORL1 and involved in OFQ/N-induced hyperalgesia and anti-analgesia, the effects of Phepsi and OFQ/N on the membrane current were studied using whole cell patch clamp recording technique in rat brain slices. 3. OFQ/N (0.01 - 1 microM) activated an inwardly rectifying type of K+ channels in ventrolateral neurons of PAG. Phepsi (0.03 - 1 microM), like OFQ/N, also activated this inward rectifier but had only 30% efficacy of OFQ/N. 4 At maximal effective concentration (1 microM), Phepsi reversed the increment of K+ conductance induced by OFQ/N (300 nM) by 46%. On the other hand, Phepsi also prevented the effect of OFQ/N if pretreated before OFQ/N. 5 It is suggested that Phepsi acts as a partial agonist of ORL1 that mediates the activation of inwardly rectifying K+ channels in ventrolateral neurons of rat periaqueductal gray.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Both OFQ/N and Pheψ activated an inwardly rectifying type of K+ channels. Cell was held at −70 mV and step to −140 mV for 100 ms followed by a ramp depolarization from −140 to −60 mV at a rate of 0.2 mV ms−1 (inset). I-V curves of membrane currents evoked by ramp commands before and after treatment with 300 nM OFQ/N (Aa) or 1 μM Pheψ (Ba). The I-V curve of peptide-elicited current was obtained by subtracting the control current from that in the presence of OFQ/N (Ab) or Pheψ (Bb). Both I-V curves show an inward rectification and reverse polarity at −94 mV (A) and −88 mV (B), which are close to the presumed K+ equilibrium potential (−91 mV).
Figure 2
Figure 2
Concentration-response curves of outward currents induced by OFQ/N and Pheψ. Cells were held at −70 mV. The changes of holding currents induced by OFQ/N and Pheψ were plotted against the peptide concentrations. The curves were fitted based on the equation I=Imax/[1+(EC50/D)n], where I represents the outward current, Imax the maximal current, D the concentration of peptide and n the Hill coefficient. The EC50 and n obtained from the curves are, respectively, 54±12 nM and 0.98 for OFQ/N and are 77±10 nM and 0.79 for Pheψ. Figures in the parenthesis are the number of cells tested.
Figure 3
Figure 3
Interactions between OFQ/N and Pheψ in eliciting the inwardly rectifying K+ conductance. Membrane currents were evoked by the same protocol as in Figure 1. (A) Cell was treated with 300 nM OFQ/N followed by further treatment with 1 μM Pheψ. (B) Cell was treated with 1 μM Pheψ followed by further treatment with 300 nM OFQ/N. The cell in (B) showed frequent spontaneous excitatory postsynaptic currents. Note that Pheψ partially reversed the effect of OFQ/N (A) and was unable to completely prevent its effect (B).

Similar articles

Cited by

References

    1. ANTON B., FEIN J., TO T., LI X., SILBERSTEIN L., EVANS C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 1996;368:229–251. - PubMed
    1. BEHBEHANI M.M. Functional characteristics of the midbrain periaqueductal gray. Prog. Neurobiol. 1995;46:575–605. - PubMed
    1. BLANTON M.G., LO TURCO J.J., KRIEGSTEIN A.R. Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Meth. 1989;30:203–210. - PubMed
    1. BUTOUR J.L., MOISAND C., MOLLEREAU C., MEUNIER J.C. [Phe1ψ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol. 1998;349:R5–R6. - PubMed
    1. CALO G., RIZZI A., MARZOLA G., GUERRINI R., SALVADORI S., BEANI L., REGOLI D., BIANCHI C. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol. 1998;125:373–378. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources